Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease

Abstract

Place plays a significant role in our health. As genetic/genomic services evolve and are increasingly seen as mainstream, especially within the field of rare disease, it is important to ensure that where one lives does not impede access to genetic/genomic services. Our aim was to identify barriers and enablers of geographical equity in accessing clinical genomic or genetic services. We undertook a systematic review searching for articles relating to geographical access to genetic/genomic services for rare disease. Searching the databases Medline, EMBASE and PubMed returned 1803 papers. Screening led to the inclusion of 20 articles for data extraction. Using inductive thematic analysis, we identified four themes (i) Current service model design, (ii) Logistical issues facing clinicians and communities, (iii) Workforce capacity and capability and iv) Rural culture and consumer beliefs. Several themes were common to both rural and urban communities. However, many themes were exacerbated for rural populations due to a lack of clinician access to/relationships with genetic specialist staff, the need to provide more generalist services and a lack of genetic/genomic knowledge and skill. Additional barriers included long standing systemic service designs that are not fit for purpose due to historically ad hoc approaches to delivery of care. There were calls for needs assessments to clarify community needs. Enablers of geographically equitable care included the uptake of new innovative models of care and a call to raise both community and clinician knowledge and awareness to demystify the clinical offer from genetics/genomics services.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

All data generated or analysed during this study are included in this published article [and its supplementary information files].

References

  1. Dummer TJB. Health geography: supporting public health policy and planning. Can Med Assoc J. 2008;178:1177–80.

    Article  Google Scholar 

  2. National Academies of Sciences Engineering and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Health Care Utilization and Adults with Disabilities. Factors that affect health-care utilization. In: Health-care utilization as a proxy in disability determination. Washington DC: National Academies Press (US); 2018.

  3. Moy E, Garcia MC, Bastian B, Rossen LM, Ingram DD, Faul M, et al. Leading causes of death in nonmetropolitan and metropolitan areas, 1999–2014, CDC. Morbid Mortal Week Rep. 2017;66.

  4. Henley SJ, Jemal A. Rural cancer control: bridging the chasm in geographic health inequity. HHS Public Access. 2018;27:1248–51.

    Google Scholar 

  5. Rocha TAH, Da Silva NC, Amaral PV, Barbosa ACQ, Rocha JVM, Alvares V, et al. Addressing geographic access barriers to emergency care services: a national ecologic study of hospitals in Brazil. Int J Equity Health. 2017;16:1–10.

    Article  CAS  Google Scholar 

  6. Neale J, Tompkins C, Sheard L. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. Health Soc Care Community. 2008;16:147–54.

    Article  Google Scholar 

  7. Jacobs B, Ir P, Bigdeli M, Annear PL, Van, Damme W. Addressing access barriers to health services: an analytical framework for selecting appropriate interventions in low-income Asian countries. Health Policy Plan. 2012;27:288–300.

    Article  Google Scholar 

  8. Bellaiche MMJ, Fan W, Walbert HJ, McClave EH, Goodnight BL, Sieling FH, et al. Disparity in access to oncology precision care: a geospatial analysis of driving distances to genetic counselors in the U.S. Front Oncol. 2012;11:689927. https://doi.org/10.3389/fonc.2021.689927.

    Article  Google Scholar 

  9. Gardner B, Doose M, Sanchez JI, Freedman AN, Moor JSD. Distribution of genomic testing resources by oncology practice and rurality: a nationally representative study. JCO Precis Oncol. 2021;5:1060–8. https://doi.org/10.1200/po.21.00109.

  10. National Academies of Sciences Engineering and Medicine. Understanding disparities in access to genomic medicine. Washington DC: The National Academies Press; 2018. 126.

  11. Barwell JG, Sullivan RBGO, Mansbridge LK, Lowry JM, Dorkins HR. Challenges in implementing genomic medicine: the 100,000 Genomes Project. J Transl Genet Genom. 2018;2:13.

  12. Best S, Brown H, Stark Z, Long JC, Ng L, Braithwaite J, Taylor N. Teamwork in clinical genomics: A dynamic sociotechnical healthcare setting. J Eval Clin Pract. 2021;27:1369–80. https://doi.org/10.1111/jep.13573. Epub 2021 May 5.

  13. Stark Z, Dolman L, Manolio TA, Ozenberger B, Hill SL, Caulfied MJ, et al. Integrating genomics into healthcare: a global responsibility. Am J Hum Genet. 2019;104:13–20.

    Article  CAS  Google Scholar 

  14. Wise AL, Manolio TA, Mensah GA, Peterson JF, Roden DM, Tamburro C, et al. Genomic medicine for undiagnosed diseases. Lancet. 2019;394:533–40.

    Article  CAS  Google Scholar 

  15. Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15:258–67.

    Article  Google Scholar 

  16. Mattick JS, Dziadek MA, Terrill BN, Kaplan W, Spigelman AD, Bowling FG, et al. The impact of genomics on the future of medicine and health. Med J Aust. 2014;201:17–20.

    Article  Google Scholar 

  17. Borzekowski DL, Guan Y, Smith KC, Erby LH, Roter DL. The Angelina effect: immediate reach, grasp, and impact of going public. Genet Med. 2014;16:516–21.

    Article  Google Scholar 

  18. Carmichael N, Tsipis J, Windmueller G, Mandel L, Estrella E. “Is it going to hurt?” The impact of the diagnostic odyssey on children and their families. J Genet Couns. 2015;24:325–35. https://doi.org/10.1007/s10897-014-9773-9. Epub 2014 Oct 4.

    Article  PubMed  Google Scholar 

  19. Moher D, Liberati A, Tetzlaff J, Altman D TPGroup. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.

    Article  Google Scholar 

  20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159.

    Article  CAS  Google Scholar 

  21. Hawker S, Payne S, Kerr C, Hardey M, Powell J. Appraising the evidence: reviewing disparate data systematically. Qual Health Res. 2002;12:1284–99.

    Article  Google Scholar 

  22. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.

    Article  Google Scholar 

  23. Boothe E, Greenberg S, Delaney CL, Cohen SA. Genetic counseling service delivery models: a study of genetic counselors’ interests, needs, and barriers to implementation. J Genet Couns. 2020:1–10.

  24. Harrison M, Birch S, Eden M, Ramsden S, Farragher T, Payne K, et al. Variation in healthcare services for specialist genetic testing and implications for planning genetic services: the example of inherited retinal dystrophy in the English NHS. J Community Genet. 2015;157–65.

  25. Kaye C, Bodurtha J, Edick M, Ginsburg S, Keehn A, Lloyd-puryear M, et al. Regional models of genetic services in the United States. Genet Med [Internet]. 2020;22:381–8. Available from https://doi.org/10.1038/s41436-019-0648-1.

    Article  CAS  Google Scholar 

  26. Triebold M, Skov K, Erickson L, Olimb S, Puumala S, Wallace I, et al. Geographical analysis of the distribution of certified genetic counselors in the United States. J Genet Couns. 2020;1–9.

  27. Villegas C, Haga SB. Access to genetic counselors in the Southern United States. J Pers Med. 2019;9:33. https://doi.org/10.3390/jpm9030033.

    Article  PubMed Central  Google Scholar 

  28. Vieira TP, Sgardioli IC, Gil-da-silva-lopes VL. Genetics and public health: the experience of a reference center for diagnosis of 22q11. 2 deletion in Brazil and suggestions for implementing genetic testing. J Community Genet. 2013;4:99–106. https://doi.org/10.1007/s12687-012-0123-z.

    Article  PubMed  Google Scholar 

  29. Penon-Portmann M, Chang J, Cheng M, Shieh JT. Genetics workforce: distribution of genetics services and challenges to health care in California. Genet Med. 2020;22:227–31.

    Article  Google Scholar 

  30. Burton H, Alberg C, Moore AT. Genetics in ophthalmology: equity in service provision? J Public Health (Oxf). 2010;32:259–66. https://doi.org/10.1093/pubmed/fdp110.

    Article  Google Scholar 

  31. Senier L, Kearney M, Orne J. Using public-private partnerships to mitigate disparities in access to genetic services: lessons from Wisconsin. Adv Med Social. 2015;16:269–305.

    Article  Google Scholar 

  32. Qian E. A comparative study of patients’ perceptions of genetic and genomic medicine services in California and Malaysia. J Community Genet. 2019;10:351–61. https://doi.org/10.1007/s12687-018-0399-8.

    Article  PubMed  Google Scholar 

  33. Cohen SA, Huziak RC, Gustafson S, Grubs RE. Analysis of advantages, limitations, and barriers of genetic counseling service delivery models. J Genet Couns. 2016;25:1010–8. https://doi.org/10.1007/s10897-016-9932-2.

    Article  PubMed  Google Scholar 

  34. Bucio D, Bustamante CD. A genetic counseling needs assessment of Mexico. Mol Genet Genom Med. 2019;7:e668. https://doi.org/10.1002/mgg3.668.

    Article  Google Scholar 

  35. Cohen SA, Marvin ML, Riley BD, Vig HS, Rousseau JA, Gustafson SL. Identification of genetic counseling service delivery models in practice: a report from the NSGC Service Delivery Model Task Force. J Genet Couns. 2013;22:411–21. https://doi.org/10.1007/s10897-013-9588-0.

    Article  PubMed  Google Scholar 

  36. Hawkins AK, Creighton S, Hayden MR. When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada. Eur J Hum Genet. 2013;21:148–53. https://doi.org/10.1038/ejhg.2012.147.

    Article  PubMed  Google Scholar 

  37. Terry AB, Wylie A, Raspa M, Vogel B, Sanghavi K, Djurdjinovic L, et al. Clinical models of telehealth in genetics: a regional telegenetics landscape. J Genet Couns. 2019;28:673–91. https://doi.org/10.1002/jgc4.1088.

    Article  PubMed  Google Scholar 

  38. Harding B, Webber C, Ruhland L, Dalgarno N, Armour CM, Birtwhistle R, et al. Primary care providers’ lived experiences of genetics in practice. J Community Genet. 2019;10:85–93. https://doi.org/10.1007/s12687-018-0364-6.

    Article  PubMed  Google Scholar 

  39. Dorfman E, Trinidad SB, Morales C, Howlett K, Burke W, Woodahl E. Pharmacogenomics in diverse practice settings: implementation beyond major. Pharmacogenomics. 2015;16:227–37.

    Article  CAS  Google Scholar 

  40. Smith AJ, Oswald D, Bodurtha J. Trends in unmet need for genetic counseling among children with special health care needs, 2001–2010. Acad Pediatr. 2015;15:544–50.

    Article  Google Scholar 

  41. Bernhardt BA, Zayac C, Pyeritz RE. Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia. Genet Med. 2011;13:812–20. https://doi.org/10.1097/GIM.0b013e31821d2e6d.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Holloway SM, Lampe AK, Lam W. Paediatric referral and attendance rates for the clinical genetics service in south-east Scotland--a comparison of a regional clinic with satellite clinics. Scott Med J. 2010;55:10–3. https://doi.org/10.1258/RSMSMJ.55.1.10.

  43. Blaes AH, Patricia IJ, McKay K, Riley D, Jatoi I, Trentham-Dietz A, et al. Factors associated with genetic testing in a cohort of breast cancer survivors. Breast J. 2019;25:1241–4.

    Article  Google Scholar 

  44. Green RF, Ari M, Kolor K, Dotson WD, Bowen S, Habarta N, et al. Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework. Genet Med. 2019;21:28–37.

    Article  Google Scholar 

  45. Lawrence-Bourne J, Dalton H, Perkins D, Farmer J, Luscombe G, Oelke N, et al. What is rural adversity, how does it affect wellbeing and what are the implications for action? Int J Environ Res Public Health. 2020;17:7205.

    Article  Google Scholar 

  46. Page-Carruth A, Windsor C, Clark M. Rural self-reliance: the impact on health experiences of people living with type II diabetes in rural Queensland, Australia. Int J Qual Stud Health Well-Being. 2014;9:24182. https://doi.org/10.3402/qhw.v9.24182.

    Article  PubMed  Google Scholar 

  47. Brown EG, Watts I, Beales ER, Maudhoo A, Hayward J, Sheridan E, et al. Videoconferencing to deliver genetics services: a systematic review of telegenetics in light of the COVID-19 pandemic. Genet Med. 2021;23:1438–49. https://doi.org/10.1038/s41436-021-01149-2. Epub 2021 Apr 6.

  48. Bonter K, Desjardins C, Currier N, Pun J, Ashbury FD. Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine. BMJ Open. 2011;1:1–7.

    Article  Google Scholar 

  49. Hamilton AB, Finley EP. Qualitative methods in implementation research: an introduction. Psychiatry Res. 2020. https://doi.org/10.1016/j.psychres.2019.112516.

Download references

Acknowledgements

The authors declare no competing financial interests in relation to the study described in the manuscript. Our study was funded through Australian Genomics, via an NHMRC Targeted Call for Research grant (GNT1113531): ‘Preparing Australia for Genomic Medicine’. The funders played no part in the study design; data collection, analysis, and interpretation; in the writing of the manuscript or in the decision to submit this manuscript for publication.

Author information

Authors and Affiliations

Authors

Contributions

SB was responsible for designing the review protocol, writing the protocol and report, screening eligible studies, extracting and analysing data, interpreting results, and lead the writing. NV supported designing the review protocol, screening eligible studies, extracting and analysing data, interpreting results and supported writing up the findings. KA liaised with the librarian, ran the searches, screening eligible studies, extracting and analysing data, interpreting results and supported writing up the findings. FC supported designing the protocol, provided expert opinion and criticism and writing up the findings. SMW supported designing the protocol, provided expert opinion and criticism and writing up the findings

Corresponding author

Correspondence to Stephanie Best.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Best, S., Vidic, N., An, K. et al. A systematic review of geographical inequities for accessing clinical genomic and genetic services for non-cancer related rare disease. Eur J Hum Genet 30, 645–652 (2022). https://doi.org/10.1038/s41431-021-01022-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41431-021-01022-5

This article is cited by

Search

Quick links